Submit Deal

DCVC BIO

HQ - Palo Alto, CA

Summary

DCVC BIO, a venture capital firm investing in deep tech and biotech companies.

Deals Overview

Total Deals7

Valued Deals7

Total Value£ 803 M

Avg. Deal Size£ 115 M

Market Context

Senior Management

Carl Hansen
CEO
Kiersten Stead
Managing Partner

Sort

15 Jun 2021|United States|Biotechnology

Target: UMOJA BIOPHARMA

Bidder: CORMORANT ASSET MANAGEMENT

13 Service Providers

1 Target | 12 Bidder

14 Dealmakers

1 Target | 13 Bidder

£ 148 M

Value

21 Oct 2021|United States|Environmental Consulting

Target: JUPITER INTEL

Bidder: SYSTEMIQ INCUBATION

13 Service Providers

2 Target | 11 Bidder

13 Dealmakers

2 Target | 11 Bidder

£ 42 M

Value

19 Apr 2022|United States|Digital Services

Target: UNLEARN

Bidder: INSIGHT PARTNERS LLC

10 Service Providers

4 Target | 6 Bidder

11 Dealmakers

4 Target | 7 Bidder

£ 38 M

Value

22 Jun 2022|United States|Alternative Fuels

Target: ZAP ENERGY

Bidder: BREAKTHROUGH ENERGY VENTURES

5 Service Providers

1 Target | 4 Bidder

10 Dealmakers

4 Target | 6 Bidder

£ 130 M

Value

17 Jun 2020|United States|Biotechnology

Target: ORCA BIO

Bidder: LIGHTSPEED VENTURE PARTNERS

6 Service Providers

1 Target | 5 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 267 M

Value

01 Mar 2023|United States|Biotechnology

Target: CHROMA MEDICINE

Bidder: ARCH VENTURE PARTNERS

18 Service Providers

1 Target | 17 Bidder

18 Dealmakers

2 Target | 16 Bidder

£ 111 M

Value

22 Feb 2024|United States|Pharmaceuticals

Target: FRONTIER MEDICINES

Bidder: GALAPAGOS NV

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 63 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy